{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T20:40:07Z","timestamp":1750538407915,"version":"3.41.0"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2022,1,25]],"date-time":"2022-01-25T00:00:00Z","timestamp":1643068800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Cystic renal cell carcinoma (RCC) refers to an indolent version of RCC composed predominantly of cysts, and it is associated with good prognosis. We showed the FDG PET\/CT findings in a patient with multiple hypermetabolic bone metastases presenting with pain in the left shoulder and upper abdomen, who was later found to have cystic RCC. FDG PET\/CT demonstrated hypermetabolic bone lesions and slight thickening of the renal cyst wall with light metabolism. This report indicates the risk of misdiagnosing cystic RCC as a renalcyst.<\/jats:p>","DOI":"10.1097\/rlu.0000000000004071","type":"journal-article","created":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T21:04:51Z","timestamp":1643317491000},"page":"369-371","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["A Renal Cyst Invaded by Infiltrating Renal Cell Carcinoma With Multiple Hypermetabolic Bone Metastases as the Initial Presentation"],"prefix":"10.1097","volume":"47","author":[{"given":"Shu","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bulin","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuena","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaming","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2022,1,25]]},"reference":[{"key":"bib1-20250621","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1309\/AH6FC77PYR2V6YAY","article-title":"Multilocular cystic renal cell carcinoma : a report of 45 cases of a kidney tumor of low malignant potential","volume":"125","year":"2006","journal-title":"Am J Clin Pathol"},{"key":"bib2-20250621","doi-asserted-by":"crossref","first-page":"W292","DOI":"10.2214\/AJR.12.9414","article-title":"Cystic renal cell carcinomas: do they grow, metastasize, or recur?","volume":"201","year":"2013","journal-title":"Am J Roentgenol"},{"key":"bib3-20250621","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.juro.2018.02.3087","article-title":"Cystic renal cell carcinoma: a report on outcomes of surgery and active surveillance in patients retrospectively identified on pretreatment imaging","volume":"200","year":"2018","journal-title":"J Urol"},{"key":"bib4-20250621","doi-asserted-by":"crossref","first-page":"W20","DOI":"10.2214\/AJR.11.6762","article-title":"Multilocular cystic renal cell carcinoma: comparison of imaging and pathologic findings","volume":"198","year":"2012","journal-title":"Am J Roentgenol"},{"key":"bib5-20250621","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/s41585-018-0034-9","article-title":"An interdisciplinary consensus on the management of bone metastases from renal cell carcinoma","volume":"15","year":"2018","journal-title":"Nat Rev Urol"},{"key":"bib6-20250621","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1097\/RLU.0000000000000875","article-title":"Preoperative evaluation of renal cell carcinoma by using 18F-FDG PET\/CT","volume":"40","year":"2015","journal-title":"Clin Nucl Med"},{"key":"bib7-20250621","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.21873\/anticanres.13214","article-title":"Clinical outcomes of 42 renal cell carcinoma patients with metastases solely to the lung who received sorafenib as second-line systemic therapy","volume":"39","year":"2019","journal-title":"Anticancer Res"},{"key":"bib8-20250621","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/14737140.2019.1559058","article-title":"Sorafenib: key lessons from over 10 years of experience","volume":"19","year":"2019","journal-title":"Expert Rev Anticancer Ther"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004071","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T20:05:54Z","timestamp":1750536354000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004071"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,25]]},"references-count":8,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000004071","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"type":"electronic","value":"1536-0229"},{"type":"print","value":"0363-9762"}],"subject":[],"published":{"date-parts":[[2022,1,25]]}}}